Evidence map›Paper›PMID 32968850›Full record

ArticleJournal of thrombosis and thrombolysis2021

Risk factors for intracerebral hemorrhage in patients with COVID-19.

Kara R Melmed, Meng Cao, Siddhant Dogra, Ruina Zhang, Shadi Yaghi, Ariane Lewis, Rajan Jain, Seda Bilaloglu, Ji Chen, Barry M Czeisler and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 7 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 7 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Neuropathologic findings of patients with COVID-19: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  6. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  7. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  8. Trial
  9. Article
  10. Article
  11. Ambient versus household PMFrontiers in public health · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review.Current treatment options in neurology · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Stroke in the COVID-19 pandemic era.Postepy psychiatrii neurologii · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Kara R MelmedDepartment of Neurology, New York University Langone Health, New York, NY, USA. kara.melmed@nyulangone.org.ORCID http://orcid.org/0000-0003-4084-8586
Meng CaoDepartment of Medicine, New York University Langone Health, New York, NY, USA.
Siddhant DograDepartment of Radiology, New York University Langone Health, New York, NY, USA.
Ruina ZhangDepartment of Medicine, New York University Langone Health, New York, NY, USA.
Shadi YaghiDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Ariane LewisDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Rajan JainDepartment of Neurosurgery, New York University Langone Health, New York, NY, USA.
Seda BilalogluDepartment of Population Health, New York University Langone Health, New York, NY, USA.
Ji ChenDepartment of Population Health, New York University Langone Health, New York, NY, USA.
Barry M CzeislerDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Eytan RazDepartment of Radiology, New York University Langone Health, New York, NY, USA.
Aaron LordDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Jeffrey S BergerDepartment of Cardiology, New York University Langone Health, New York, NY, USA.
Jennifer A FronteraDepartment of Neurology, New York University Langone Health, New York, NY, USA.
NYU Langone Health · US

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
NIA NIH HHS 3P30AG066512-01S1NIA NIH HHS P30 AG066512
6 · The paper itself

Abstract

Intracerebral hemorrhage (ICH) can be a devastating complication of coronavirus disease (COVID-19). We aimed to assess risk factors associated with ICH in this population. We performed a retrospective cohort study of adult patients admitted to NYU Langone Health system between March 1 and April 27 2020 with a positive nasopharyngeal swab polymerase chain reaction test result and presence of primary nontraumatic intracranial hemorrhage or hemorrhagic conversion of ischemic stroke on neuroimaging. Patients with intracranial procedures, malignancy, or vascular malformation were excluded. We used regression models to estimate odds ratios and 95% confidence intervals (OR, 95% CI) of the association between ICH and covariates. We also used regression models to determine association between ICH and mortality. Among 3824 patients admitted with COVID-19, 755 patients had neuroimaging and 416 patients were identified after exclusion criteria were applied. The mean (standard deviation) age was 69.3 (16.2), 35.8% were women, and 34.9% were on therapeutic anticoagulation. ICH occurred in 33 (7.9%) patients. Older age, non-Caucasian race, respiratory failure requiring mechanical ventilation, and therapeutic anticoagulation were associated with ICH on univariate analysis (p < 0.01 for each variable). In adjusted regression models, anticoagulation use was associated with a five-fold increased risk of ICH (OR 5.26, 95% CI 2.33-12.24, p < 0.001). ICH was associated with increased mortality (adjusted OR 2.6, 95 % CI 1.2-5.9). Anticoagulation use is associated with increased risk of ICH in patients with COVID-19. Further investigation is required to elucidate underlying mechanisms and prevention strategies in this population.

Indexed as

Cerebral HemorrhageCOVID-19Respiration, ArtificialRespiratory InsufficiencyAgedAnticoagulantsCohort StudiesFemaleHumansIschemic StrokeMaleNeuroimagingRisk AssessmentRisk FactorsSARS-CoV-2United StatesAnticoagulantsAnticoagulationCOVID-19Hemorrhagic strokeIntracerebral hemorrhageMechanical ventilation

Identifiers

PMID32968850
PMCPMC7511245
OpenAlexW3089109130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.